Anatomic Site
You have full text access to this OnlineOpen article
Intra-arterial preoperative cytostatic treatment versus preoperative irradiation : A prospective, randomized study of lingual and sublingual carcinomas (pages 1381–1386)George Szabó, Joachim Kreidler, Karl Hollmann, Adam Kovács, George Németh, Zsolt Németh, Zoltán Tóth-Bagi and Joseph Barabás
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1381::AID-CNCR1>3.0.CO;2-V
In this study, the long term survival results subsequent to preoperative intra-arterial chemotherapy or preoperative radiotherapy were practically the same. Regarding postoperative quality of life, patients who underwent intra-arterial chemotherapy appeared to be in a slightly more favorable situation.
You have full text access to this OnlineOpen article
Development of a new staging system for recurrent oral cavity and oropharyngeal squamous cell carcinoma (pages 1387–1395)Peter D. Lacy, Edward L. Spitznagel Jr. and Jay F. Piccirillo
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1387::AID-CNCR2>3.0.CO;2-M
Significant variables affecting survival were combined to create a new composite staging system for recurrent squamous cell carcinomas of the oral cavity and oropharynx.
You have full text access to this OnlineOpen article
Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus (pages 1396–1405)Goh Ikeda, Shuji Isaji, Bidhan Chandra Das, Masatoshi Watanabe and Yoshifumi Kawarada
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1396::AID-CNCR3>3.0.CO;2-H
The biologic factors of Ki-67 labeling index and p53 expression as well as clinicopathologic factors can be used as independent prognostic factors for esophageal carcinoma. However, the results of this study do not support cyclin D1 expression as a prognostic factor.
You have full text access to this OnlineOpen article
Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae (pages 1406–1413)Manabu Muto, Atsushi Ohtsu, Shin-ichi Miyamoto, Kei Muro, Narikazu Boku, Satoshi Ishikura, Mitsuo Satake, Takashi Ogino, Hisao Tajiri and Shigeaki Yoshida
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1406::AID-CNCR4>3.0.CO;2-3
This study demonstrates that the presence of malignant fistulae does not contraindicate chemoradiotherapy because it provides a better chance of survival and oral alimentation.
You have full text access to this OnlineOpen article
Depressed adenoma of the duodenum in patients with familial adenomatous polyposis : Endoscopic and immunohistochemical features (pages 1414–1420)Takayuki Matsumoto, Mitsuo Iida, Shotaro Nakamura, Kazuoki Hizawa, Mitsuru Mizuno, Takashi Yao, Masazumi Tsuneyoshi and Masatoshi Fujishima
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1414::AID-CNCR5>3.0.CO;2-#
Depressed duodenal adenoma has higher proliferative activity than polypoid adenoma in patients with familial adenomatous polyposis.
You have full text access to this OnlineOpen article
Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma (pages 1421–1430)Alexandra Giatromanolaki, George P. Stathopoulos, Eleni Tsiobanou, Costandina Papadimitriou, Vassilios Georgoulias, Kevin C. Gatter, Adrian L. Harris and Michael I. Koukourakis
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1421::AID-CNCR6>3.0.CO;2-X
High intratumoral vessel density combined with p53 protein nuclear accumulation has been shown to predict poor prognosis of patients with Dukes Stage B and Stage C (AJCC/UICC Stage I and III) colorectal adenocarcinoma. High CD31 positive lymphocytic infiltration, but not p53 or bcl-2 expression, was associated with increased vascular density.
You have full text access to this OnlineOpen article
Telomere shortening and the clinicopathologic characteristics of human colorectal carcinomas (pages 1431–1436)Sho Takagi, Yoshitaka Kinouchi, Nobuo Hiwatashi, Masaki Chida, Fumio Nagashima, Seiichi Takahashi, Kenichi Negoro, Tooru Shimosegawa and Takayoshi Toyota
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1431::AID-CNCR7>3.0.CO;2-R
In invasive colorectal carcinomas, the frequency of telomere shortening was significantly higher in nonulcerated polypoid carcinomas than in ulcerated carcinomas, and was also significantly higher in ascending colon carcinomas than in sigmoid colon or rectal carcinomas. However, in these tumors, telomerase activity was not correlated with telomere length.
You have full text access to this OnlineOpen article
High prevalence of transfusion-transmitted virus among patients with non-B, non-C hepatocellular carcinoma (pages 1437–1440)Naoki Nakagawa, Jiro Ikoma, Tomoaki Ishihara, Noriko Yasui, Naoki Fujita, Motoh Iwasa, Masahiko Kaito, Shozo Watanabe and Yukihiko Adachi
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1437::AID-CNCR8>3.0.CO;2-I
High prevalence of transfusion-transmitted virus (TTV) infection was detected among patients with non-B, non-C hepatocellular carcinoma, suggesting a potential pathogenetic association between TTV infection and hepatocellular carcinoma.
You have full text access to this OnlineOpen article
K-ras mutations in duodenal aspirate without secretin stimulation for screening of pancreatic and biliary tract carcinoma (pages 1441–1448)Hiroyuki Watanabe, Aiguli Ha, Yu-Xin Hu, Koushiro Ohtsubo, Yasushi Yamaguchi, Yoshiharu Motoo, Takashi Okai, Daishu Toya, Nobuyoshi Tanaka and Norio Sawabu
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1441::AID-CNCR9>3.0.CO;2-I
K-ras mutation at codon 12 (KRM) in duodenal aspirates (DA), easily obtained without secretin stimulation immediately after endoscopic retrograde cholangiopancreatography by the mutant allele specific amplification (MASA) method, occurred in 25 (66%) of 38 patients with pancreatic carcinoma and 12 (55%) of 22 patients with biliary tract carcinoma. These results suggest that detection of KRM in DA by MASA is useful for the screening for both pancreatic and biliary tract carcinoma.
You have full text access to this OnlineOpen article
Predictive value of Ki-67, p53 protein, and DNA content in the diagnosis of gastric carcinoma (pages 1449–1454)Nobuyuki Igarashi, Makoto Takahashi, Haruo Ohkubo, Kousaku Omata, Ryuichi Iida and Shigeru Fujimoto
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1449::AID-CNCR10>3.0.CO;2-D
Preoperative Ki-67 and p53 analyses along with routine imaging findings were studied retrospectively to determine their role in making an accurate preoperative diagnosis of gastric carcinoma. The presence of p53 overexpression and a high Ki-67 labeling index in the biopsied and surgically resected specimens correlated closely with advanced stage gastric carcinoma that was difficult to distinguish from early gastric carcinoma based on preoperative imaging findings.
You have full text access to this OnlineOpen article
The expression of transforming growth factor-β1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma (pages 1455–1462)Hiroaki Saito, Shunichi Tsujitani, Shinichi Oka, Akira Kondo, Masahide Ikeguchi, Michio Maeta and Nobuaki Kaibara
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L
Transforming growth factor-β1 might be associated with tumor progression by indirectly stimulating angiogenesis through the up-regulation of vascular endothelial growth factor expression in gastric carcinoma.
You have full text access to this OnlineOpen article
Gemcitabine plus vinorelbine in nonsmall cell lung carcinoma patients age 70 years or older or patients who cannot receive cisplatin (pages 1463–1469)Jaime Feliu, Luis López Gómez, Caterina Madroñal, Enrique Espinosa, Javier Espinosa, Carlos García Girón, Beatriz Martínez, Javier Castro, Isabel De la Gándara and Manuel González Barón, for the Oncopaz Cooperative Group
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1463::AID-CNCR12>3.0.CO;2-N
The combination of gemcitabine and vinorelbine has been found to show moderate efficacy for the treatment of elderly patients with nonsmall cell lung carcinoma and is well tolerated, except in those patients age ≥ 75 years. In this group the risk of myelosuppression is high and the use of granulocyte-colony stimulating factor should be considered with the administration of such treatment.
You have full text access to this OnlineOpen article
Scintigraphic prediction of resistance to radiation and chemotherapy in patients with lung carcinoma : Technetium 99m-tetrofosmin and thallium-201 dual single photon emission computed tomography study (pages 1470–1479)Mitsutaka Fukumoto, Daisuke Yoshida, Naoko Hayase, Atsushi Kurohara, Naoki Akagi and Shoji Yoshida
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1470::AID-CNCR13>3.0.CO;2-S
Radioresistance and multidrug resistance (MDR) were examined in 30 untreated lung carcinoma patients using Technetium-99m (99mTc)-tetrofosmin and thallium-201 dual single photon emission computed tomography. Low 99mTc-tetrofosmin retention was predictive of therapeutic resistance, including radioresistance and MDR, whereas thallium-201 retention alone did not appear to be a significant prognostic factor.
You have full text access to this OnlineOpen article
A randomized clinical trial comparing concurrent and alternating thoracic irradiation for patients with limited small cell lung carcinoma (pages 1480–1487)Bernard Lebeau, Thierry Urban, Jeanne-Marie Bréchot, Dominique Paillotin, Jean Vincent, Pascal Leclerc, Paul Meekel, Pierre L'Her, François-Xavier Lebas and Claude Chastang, for the “Petites Cellules” Group
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1480::AID-CNCR14>3.0.CO;2-O
In this randomized, controlled clinical trial, two modes of thoracic irradiation were compared. Although not significant, a trend toward a difference (P = 0.15) was observed for survival in favor of the alternating mode. Lethal pulmonary fibrosis was more frequent with the concurrent mode (P = 0.05). As in other trials, the lack of cisplatin use was probably a disadvantage to overall survival in comparison with trials in which cisplatin was used.
You have full text access to this OnlineOpen article
Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions (pages 1488–1495)Jaume Ferrer, Ma Antonia Villarino, Gloria Encabo, Enriqueta Felip, Begoña Bermejo, Sara Vilà and Ramon Orriols
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1488::AID-CNCR15>3.0.CO;2-Y
The results of the current study indicate that CYFRA 21-1, carcinoembryonic antigen, and CA 125 determinations in pleural fluid increase the sensitivity of pleural fluid cytology in the diagnosis of malignant pleural effusion.
You have full text access to this OnlineOpen article
Intensive short term therapy with granulocyte-macrophage–colony stimulating factor support, similar to therapy for acute myeloblastic leukemia, does not improve overall results for adults with acute lymphoblastic leukemia (pages 1496–1505)Norbert Ifrah, Francis Witz, Jean-Pierre Jouet, Sylvie François, Thierry Lamy, Claude Linassier, Bernard Pignon, Christian Berthou, Denis Guyotat, Jean-Yves Cahn and Jean-Luc Harousseau, and the GOELAMS Group
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1496::AID-CNCR16>3.0.CO;2-#
A schedule similar to the therapy schedule for acute myeloblastic leukemia patients allows a high rate of complete remission in adult acute lymphoblastic leukemia patients but fails to improve relapse rate and survival. In this study, no major improvement was obtained with recombinant granulocyte-macrophage–colony stimulating factor therapy.
You have full text access to this OnlineOpen article
A longer breast carcinoma screening interval for women age older than 65 years? (pages 1506–1510)Rob Boer, Harry J. de Koning and Paul J. van der Maas
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1506::AID-CNCR17>3.0.CO;2-2
Although a longer sojourn time for preclinical breast carcinoma should not necessarily be accompanied by a longer screening interval, a short interval does not appear to be very efficient.
You have full text access to this OnlineOpen article
Factors associated with axillary lymph node metastasis from breast carcinoma : Descriptive and predictive analyses (pages 1511–1519)Peter H. Gann, Susan A. Colilla, Susan M. Gapstur, David J. Winchester and David P. Winchester
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1511::AID-CNCR18>3.0.CO;2-D
Multivariate analyses of large data sets from the Patient Care Evaluation surveys and the National Cancer Data Base of the American College of Surgeons confirm and quantify the independent associations of age, race, tumor location, grade, ploidy, histologic type, estrogen receptor and progesterone receptor status with the probability of axillary lymph node metastasis from breast carcinoma. However, prediction models incorporating these variables fail to identify large subsets of patients who could avoid axillary dissection.
You have full text access to this OnlineOpen article
Long term results of definitive radiotherapy for cervical carcinoma using four applications of high dose rate afterloading (pages 1520–1527)Martin Busch, Harald Meden, Fattahi Meibodi, Eckhart Dühmke and Walther Kuhn
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1520::AID-CNCR19>3.0.CO;2-C
In this study of radiotherapy for patients with cervical carcinoma, external beam radiotherapy was combined with 4 afterloading high dose rate applications (total of 30 grays). This was found to be clinically feasible and resulted in good survival rates and a low rate of side effects.
You have full text access to this OnlineOpen article
The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix (pages 1528–1536)Michelle Grogan, Gillian M. Thomas, Iris Melamed, Frances L. W. Wong, Robert G. Pearcey, Paul K. Joseph, Lorraine Portelance, Juanita Crook and Keith D. Jones
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E
Hemoglobin level during radiation is the most significant independent prognostic factor other than stage of disease for patients with carcinoma of the cervix who are treated with radiotherapy. The authors hypothesized that the negative impact of a low hemoglobin level at presentation can be overcome by blood transfusions to maintain the patient's hemoglobin level at ≥ 120 g/L during radiotherapy.
You have full text access to this OnlineOpen article
Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma (pages 1537–1543)Bor-Ching Sheu, Su-Ming Hsu, Hong-Nerng Ho, Rong-Hwa Lin, Pao-Ling Torng and Su-Cheng Huang
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D
Decreased proportions of tumor-infiltrating CD4+ T cells with reversed CD4/CD8 ratios are highly correlated with rapid tumor growth and lymph node metastasis in cervical carcinoma patients.
You have full text access to this OnlineOpen article
Ovarian dysplasia in prophylactic oophorectomy specimens : Cytogenetic and morphometric correlations (pages 1544–1550)Liane Deligdisch, Joan Gil, Hedviga Kerner, Hai Shan Wu, Dan Beck and Ruth Gershoni-Baruch
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I
Ovarian dysplasia was identified in 77.6% of prophylactically removed ovaries from women at high risk for ovarian carcinoma. A new morphometric method based on autocorrelation coefficient combined with nuclear measurements proved to be a powerful discriminator.
You have full text access to this OnlineOpen article
Overexpression of focal adhesion kinase, a protein tyrosine kinase, in ovarian carcinoma (pages 1551–1556)Patricia L. Judson, Xiaping He, William G. Cance and Linda Van Le
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:6<1551::AID-CNCR23>3.0.CO;2-P
Focal adhesion kinase (FAK) is a tyrosine kinase that is implicated in tumor invasion and metastasis. In this study, FAK was found to be significantly overexpressed in ovarian carcinoma as compared with normal ovarian tissue.
You have full text access to this OnlineOpen article
Defining biochemical cure for prostate carcinoma patients treated with external beam radiation therapy (pages 1557–1566)Larry L. Kestin, Frank A. Vicini, Ellen L. Ziaja, Jannifer S. Stromberg, Robert C. Frazier and Alvaro A. Martinez
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1557::AID-CNCR24>3.0.CO;2-2
Patients with localized prostate carcinoma who do not experience biochemical failure within 5 years of treatment with conventional external beam radiation therapy have a very high probability of biochemical cure. Patients who achieve a prostate specific antigen nadir ≤ 0.4 ng/mL and require ≥ 2.0 years to reach this nadir have the highest probability of cure.
You have full text access to this OnlineOpen article
Second primary tumors after prostate carcinoma (pages 1567–1570)Fabio Levi, Lalao Randimbison, Van-Cong Te, Georges Erler and Carlo La Vecchia
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1567::AID-CNCR25>3.0.CO;2-Z
This dataset indicates that the incidence rate of all neoplasms is significantly reduced in men diagnosed with prostate carcinoma. Selection of the population, underregistration, and reduced surveillance in elderly men with prostate carcinoma, may, at least in part, explain this reduced risk. No excess risk was observed for tobacco-related neoplasms nor for urologic or colorectal carcinomas.
You have full text access to this OnlineOpen article
Intratesticular leiomyosarcoma in a young man after high dose doping with oral-turinabol : A case report (pages 1571–1575)Michael Froehner, Rainer Fischer, Steffen Leike, Oliver W. Hakenberg, Birgit Noack and Manfred P. Wirth
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1571::AID-CNCR26>3.0.CO;2-C
This article presents a case of an intratesticular leiomyosarcoma in a 32-year-old man and discusses the possible cocarcinogenic role of systematic long term, high dose Oral-Turinabol (4-chloro-1-dehydro-17α-methyltestosterone).
You have full text access to this OnlineOpen article
Morphologic evidence that analgesic-induced kidney pathology contributes to the progression of tumors of the renal pelvis (pages 1576–1582)John H. Stewart, John B. Hobbs and Margaret R. E. McCredie
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1576::AID-CNCR27>3.0.CO;2-V
Transitional cell carcinoma of the renal pelvis tends to be of a higher grade in those patients who have consumed >1 kg of phenacetin-containing analgesics or those who have histologic evidence of analgesic nephropathy, suggesting that prior analgesic abuse contributes directly or indirectly to tumor progression at this site. Because exposure to phenacetin itself ceased at least 14 years prior to the diagnosis of the tumors discussed in the current study, an indirect effect through analgesic-induced renal pathology was implicated as the agent responsible for tumor progression.
You have full text access to this OnlineOpen article
Predicting metastasis of pheochromocytomas using DNA flow cytometry and immunohistochemical markers of cell proliferation : A positive correlation between MIB-1 staining and malignant tumor behavior (pages 1583–1589)Heather M. Brown, Richard A. Komorowski, Stuart D. Wilson, Michael J. Demeure and Yong-ran Zhu
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1583::AID-CNCR28>3.0.CO;2-#
In this study, cell cycle analysis and, in particular, assessment of the MIB-1 nuclear proliferation marker were useful in the histologic evaluation of pheochromocytoma, as MIB-1 was expressed only in malignant tumors.
You have full text access to this OnlineOpen article
Sequential chemotherapy (etoposide, vinblastine, and doxorubicin) and subtotal lymph node radiation for patients with localized hodgkin disease and unfavorable prognostic features : A phase II cancer and leukemia group B study (9051) (pages 1590–1595)Todd H. Wasserman, Gina R. Petroni, Frederick E. Millard, Chung-Taik Chung, Maurice Barcos, Jeff L. Johnson, George P. Canellos and Bruce A. Peterson
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1590::AID-CNCR29>3.0.CO;2-4
The combination of etoposide, vinblastine, and doxorubicin, an alternative chemotherapy for patients with Hodgkin disease, was coupled with radiation in this Phase II study.
General Topic
Cancer Biology
You have full text access to this OnlineOpen article
Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice (pages 1596–1601)Chris Theodossiou, Nebojsa Skrepnik, Everett G. Robert, Chandan Prasad, Thomas W. Axelrad, David V. Schapira and Jay D. Hunt
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1596::AID-CNCR30>3.0.CO;2-C
Propylthiouracil-induced hypothyroidism resulted in reduced growth of implanted lung adenocarcinoma and prostate adenocarcinoma tumors in nude mice.
Pediatric Oncology
You have full text access to this OnlineOpen article
Metastases detected at the time of diagnosis of primary pediatric extremity osteosarcoma at diagnosis : Imaging features (pages 1602–1608)Sue C. Kaste, Charles B. Pratt, Alvida M. Cain, Dana J. Jones-Wallace and Bhaskar N. Rao
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1602::AID-CNCR31>3.0.CO;2-R
The incidence rate of computed tomography detected pulmonary metastases is 14% at diagnosis and is 0.5% for bone metastases in patients with primary extremity osteosarcoma. The number of pulmonary metastases at diagnosis and the number of lobes involved are predictive of outcome.
Psychosomatic Elements of Follow-Up
You have full text access to this OnlineOpen article
Symptom reporting in cancer patients II : Relations to social desirability, negative affect, and self-reported health behaviors (pages 1609–1620)Michael Koller, Karina Heitmann, Jochen Kussmann and Wilfried Lorenz
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1609::AID-CNCR32>3.0.CO;2-3
The current study investigated whether social desirability, in addition to negative affect, is a variable that influences cancer patients' symptom reporting and their reporting of self-initiated health behaviors. Patients' reports of symptoms and global quality of life, but not their reports of health behaviors, were strongly associated with social desirability and negative affect, even when objective health and demographic variables were held constant.
Sarcoma: Detection of Metastasis
You have full text access to this OnlineOpen article
Uptake of radiolabeled somatostatin analog is detectable in patients with metastatic foci of sarcoma (pages 1621–1627)Jonathan W. Friedberg, Annick D. Van den Abbeele, Kathleen Kehoe, Samuel Singer, Christopher D. Fletcher and George D. Demetri
Article first published online: 20 NOV 2000 | DOI: 10.1002/(SICI)1097-0142(19991015)86:8<1621::AID-CNCR33>3.0.CO;2-M
Seventeen patients with metastatic sarcoma underwent imaging via somatostatin-receptor scintigraphy. Seventy-one percent of patients with advanced soft-tissue sarcoma had increased uptake in regions of known metastatic disease.